A trader works on the floor of the New York Stock Exchange.

Check out the companies making headlines after the bell Tuesday:

Biotechnology provider Gilead Sciences blew past earnings projections with adjusted earnings of $3.15 a share, 44 cents above estimates, on revenue of $8.24 billion, which was also above estimates. The stock rose about 3 percent after hours.